Trial record 1 of 1 for:    Immunotherapy with hLL1-DOX
Previous Study | Return to List | Next Study

Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL

This study has suspended participant recruitment.
(The study is suspended while the protocol is being modified.)
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.
ClinicalTrials.gov Identifier:
NCT01585688
First received: April 23, 2012
Last updated: June 18, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)